Drag a card by its title · ⚙ to size, swap or remove
⠿
Who
SFSeymour Howard Fein
Cro/Cmo
Company insider
Files Form 4 as: Cro/Cmo, Mateon Therapeutics.
⠿
In numbers
- Trades disclosed
- 2
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Jul 2026
- Last trade
- 10 Jul 2026
- Last filed
- 23 Jul 2026
⠿
Companies traded
Where they are an officerMateon TherapeuticsOfficer · Biotechnology · last 10 Jul 20260 buys · 0 sells
⠿
Activity over time
Not enough dated trades to draw.
⠿
Every trade
| Traded | Company | What | Amount | |
|---|
| 10 Jul 2026filed 23 Jul 2026 | Mateon Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250 at $0.00 | filing |
| 10 Jul 2026filed 23 Jul 2026 | Oncotelic Therapeuticsoption or derivative | SEC FORM 4 Code A | —250 at $0.00 | filing |
⠿
News
No headline names them, or the companies they trade most, lately.
⠿
Sectors
No trade we could place in a sector.
⠿
Related people
Steven W. KingDirector · Director at Oncotelic Therapeutics, filing Form 4 there in the last year Anthony E. Maida IIIDirector and Cmo - Trans. Med. · Director and Cmo - Trans. Med. at Oncotelic Therapeutics, filing Form 4 there in the last year Vuong TrieuChairman and CEO · Chairman and CEO at Oncotelic Therapeutics, filing Form 4 there in the last year Amit B. ShahCFO · CFO at Oncotelic Therapeutics, filing Form 4 there in the last year Saran SaundCbo · Cbo at Oncotelic Therapeutics, filing Form 4 there in the last year